AIDS Drug Assistance Programs (ADAPs) provide life-saving HIV treatments to low income, uninsured, and underinsured individuals living with HIV/AIDS in all 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the U.S. Virgin Islands, American Samoa, the Federated States of Micronesia, Guam, the Northern Mariana Islands, and the Republic of the Marshall Islands. In addition, some ADAPs provide insurance continuation and Medicare Part D wrap-around services to eligible individuals. ADAPs are a component of the federal Ryan White Part B program that provides necessary medical and support services to low income, uninsured, and underinsured individuals living with HIV/AIDS in all states, territories and associated jurisdictions.
The Annual Report of NASTAD’s National ADAP Monitoring Project is based on a comprehensive survey of all ADAPs. This 16th release of the Annual Report updates prior findings with data from ADAP’s fiscal year 2010 as well as provides a detailed snapshot of data from the month of June 2010. Modules of the Annual Report reflect the latest available data and discusses recent policy and programmatic changes affecting ADAPs.
To provide interested stakeholders with more timely information, NASTAD released the 2011 National ADAP Monitoring Project Annual Report in several modules. Detailed information related to ADAP budgets, client enrollment and utilization, client demographics, program eligibility, and program management and administration are included in Module One. Module Two includes detailed information on prescription distribution and payment methods, expenditures and prescriptions filled, insurance coordination, ADAP coordination with Medicare Part D, ADAP coordination with Pre-existing Condition Insurance Plans (PCIPs), and updated client enrollment and utilization. A final, supplemental module highlights hepatitis treatments. These modules will be combined into a final, comprehensive report.
Summary slide sets for each module are also available at www.NASTAD.org.
